Yamashita Health Care Holdings,Inc. (9265.T)
JPY 2805.0
(0.0%)
JPY 2805.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.23 Billion JPY | -16.36% |
| 2022 | 1.35 Billion JPY | 14.85% |
| 2021 | 1.24 Billion JPY | -0.07% |
| 2020 | 1.24 Billion JPY | 46.66% |
| 2019 | 833.23 Million JPY | 0.84% |
| 2018 | 596.71 Million JPY | 23.76% |
| 2017 | 589.53 Million JPY | 90.51% |
| 2016 | 352 Million JPY | -50.51% |
| 2015 | 712.99 Million JPY | 5.16% |
| 2014 | 678 Million JPY | -32.47% |
| 2013 | 1 Billion JPY | 45.09% |
| 2012 | 813.77 Million JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 233.25 Million JPY | 22.6% |
| 2023 Q4 | 193 Million JPY | -28.78% |
| 2023 FY | - JPY | -16.36% |
| 2023 Q3 | 271 Million JPY | -37.27% |
| 2023 Q2 | 432 Million JPY | 101.87% |
| 2023 Q1 | 214 Million JPY | -21.03% |
| 2022 FY | - JPY | 14.85% |
| 2022 Q3 | 312 Million JPY | -11.11% |
| 2022 Q2 | 351 Million JPY | 27.64% |
| 2022 Q4 | 271 Million JPY | -13.14% |
| 2022 Q1 | 275 Million JPY | 180.9% |
| 2021 Q4 | 97.89 Million JPY | -52.78% |
| 2021 Q1 | 222.22 Million JPY | -26.81% |
| 2021 Q2 | 480.4 Million JPY | 116.18% |
| 2021 Q3 | 207.31 Million JPY | -56.85% |
| 2021 FY | - JPY | -0.07% |
| 2020 Q4 | 303.62 Million JPY | 14.58% |
| 2020 Q1 | 84.27 Million JPY | -30.76% |
| 2020 Q2 | 377.87 Million JPY | 348.36% |
| 2020 Q3 | 264.99 Million JPY | -29.87% |
| 2020 FY | - JPY | 46.66% |
| 2019 FY | - JPY | 0.84% |
| 2019 Q2 | 458.72 Million JPY | 260.29% |
| 2019 Q3 | -59.81 Million JPY | -113.04% |
| 2019 Q4 | 121.72 Million JPY | 303.51% |
| 2019 Q1 | 127.32 Million JPY | -61.72% |
| 2018 Q4 | 332.56 Million JPY | 292.05% |
| 2018 Q3 | 84.82 Million JPY | -60.38% |
| 2018 Q2 | 214.09 Million JPY | 2063.12% |
| 2018 FY | - JPY | 23.76% |
| 2018 Q1 | -10.9 Million JPY | -102.5% |
| 2017 Q3 | 32.5 Million JPY | -77.51% |
| 2017 Q1 | -86.5 Million JPY | -137.69% |
| 2017 FY | - JPY | 90.51% |
| 2017 Q4 | 436.69 Million JPY | 1243.67% |
| 2017 Q2 | 144.5 Million JPY | 267.05% |
| 2016 FY | - JPY | -50.51% |
| 2016 Q4 | 229.5 Million JPY | 897.83% |
| 2016 Q2 | 80.5 Million JPY | 2112.5% |
| 2016 Q1 | -4 Million JPY | -101.11% |
| 2016 Q3 | 23 Million JPY | -71.43% |
| 2015 Q4 | 360 Million JPY | 264.56% |
| 2015 Q1 | 29.75 Million JPY | -91.45% |
| 2015 FY | - JPY | 5.16% |
| 2015 Q2 | 229 Million JPY | 669.75% |
| 2015 Q3 | 98.75 Million JPY | -56.88% |
| 2014 Q3 | 90.75 Million JPY | -64.69% |
| 2014 Q2 | 257 Million JPY | 6147.06% |
| 2014 Q1 | -4.25 Million JPY | -101.91% |
| 2014 FY | - JPY | -32.47% |
| 2014 Q4 | 347.75 Million JPY | 283.2% |
| 2013 Q3 | 239 Million JPY | -31.81% |
| 2013 Q4 | 222.75 Million JPY | -6.8% |
| 2013 FY | - JPY | 45.09% |
| 2013 Q1 | 192 Million JPY | -19.67% |
| 2013 Q2 | 350.5 Million JPY | 82.55% |
| 2012 Q2 | 227 Million JPY | 0.0% |
| 2012 FY | - JPY | 0.0% |
| 2012 Q3 | 79.75 Million JPY | -64.87% |
| 2012 Q4 | 239 Million JPY | 199.69% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| OLBA HEALTHCARE HOLDINGS, Inc. | 2.79 Billion JPY | 55.759% |
| Alfresa Holdings Corporation | 51.97 Billion JPY | 97.624% |
| Vital KSK Holdings, Inc. | 8.84 Billion JPY | 86.033% |
| WIN-Partners Co., Ltd. | 2.91 Billion JPY | 57.648% |
| MediPal Holdings Corporation | 65.31 Billion JPY | 98.109% |
| AS ONE Corporation | 12.65 Billion JPY | 90.241% |
| Suzuken Co., Ltd. | 51.57 Billion JPY | 97.606% |